Thursday, November 04, 2010

One Month to Go!

One month from today is the big 26.2 miler! I've been able to take a break from running this week, but next week is our last BIG week! We will run a total of 20 miles Monday through Wednesday and then a 20 mile run on Friday! After that, our mileage will start to back down again so that our body can recover in preparation for the race. I am still trying to raise more money for St Jude until race day. Please consider making a donation to St Jude. You can click the link below and it will take you directly to a secure website where you can donate online.

If you have a blog of your own, please repost this!

I've shared some of these before, but here are some quick facts about St Jude:

The daily operating cost for St. Jude is nearly $1.5 million, which is primarily covered by public contributions.

During the past five years, 81 cents of every dollar received has supported the research and treatment at St. Jude.

St. Jude recently completed an extensive expansion program that bolstered the hospital’s research and treatment efforts, while more than doubling the size of its original campus. The campus now has 2.5 million square feet of research, clinical and administrative space dedicated to finding cures and saving children. The expansion included the Children’s GMP, LLC, currently the nation’s only pediatric research center on-site facility for the research and production of highly specialized treatments and vaccines; an expanded Department of Immunology; and a new Department of Chemical Biology and Therapeutics for discovery of new drugs.

The Chili’s Care Center, opened in November 2007, integrates patient care and research where rapidly evolving CT (computerized tomography) and MR (magnetic resonance) technologies keep St. Jude at the cutting edge for radiation therapy in a pediatric/adolescent setting. Additionally, a state-of-the-art cyclotron enables St. Jude researchers to undertake many important new PET (positron emission tomography) studies. These imaging techniques facilitate the rapid evaluation of new therapeutic approaches and help choose those most likely to be successful.

St. Jude pioneered a combination of chemotherapy, radiation and surgery to treat childhood cancers.

Peter C. Doherty, PhD, of the St. Jude Immunology department, won the Nobel Prize for Physiology or Medicine in 1996. He shares the award with Rolf M. Zinkernagel, MD, of the University of Zurich. Their findings have led to breakthroughs in the understanding and treatment of viral infections and cancers, and in the development of organ transplant procedures and vaccines.

St. Jude patients are referred by a physician, and generally have a disease currently under study and are eligible for a current research protocol on clinical research trials.

St. Jude researchers and doctors are treating children with genetic immune defects and pediatric AIDS, as well as using new drugs and therapies to fight infections.

St. Jude was the first institution to develop a cure for sickle cell disease with a bone marrow transplant and has one of the largest pediatric sickle cell programs in the country.

No comments: